The Trump administration’s threat of pharmaceutical tariffs could risk significant political backlash, as the drug industry ...

The U.S. imports many of its pharmaceuticals ... professor of law at UC Law San Francisco told Newsweek any price increase would fall on patients to cover: "Drug companies don't base prices ...

President Trump's MFN proposal will create many adverse consequences including reduced access to medicines, diminished drug ...

Instead, patient advocates and drug supply chain experts warn, tariffs are likely to drive the price ... make it so that it’s no longer profitable to sell that drug in the United States.” ...

The chief executive of generic drugmaker Sandoz said a proposal by the CEOs of Novartis and Sanofi to introduce a Europe-wide ...

Pharmacy benefit managers (PBMs) are up to bat in the perpetual blame game between PBMs and the pharmaceutical industry. | ...

Omar Abuattieh of Holmdel does not lack for ambition or compassion, hoping his $30,000 Truman scholarship can help him fix the morass of drug prices.

European drugmakers are urging the EU to allow higher medicine prices, warning that without stronger investment incentives, ...